Infectious Diseases (except HIV/AIDS)
Showing page 165 of 716 pages of list content
-
Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru
This article's authors -
Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel
This article's authors -
Immunogenicity and safety of the CoronaVac inactivated SARS-CoV-2 vaccine in people with underlying medical conditions: a retrospective study
This article's authors -
Outcomes of convalescent plasma with defined high- versus lower-neutralizing antibody titers against SARS-CoV-2 among hospitalized patients: CoronaVirus Inactivating Plasma (CoVIP), double-blind phase 2 study
This article's authors -
Epidemiological and clinical features of SARS-CoV-2 Infection in children during the outbreak of Omicron Variant in Shanghai, March 7-March 31, 2022
This article's authors -
Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages
This article's authors -
Omicron infection induces low-level, narrow-range SARS-CoV-2 neutralizing activity
This article's authors -
Then and NOW: A Prospective Population-Level Validation of the Abbott ID NOW SARS-CoV-2 Device Implemented in Multiple Settings for Testing Asymptomatic and Symptomatic Individuals
This article's authors -
Omicron sub-lineages BA.4/BA.5 escape BA.1 infection elicited neutralizing immunity
This article's authors -
A methodology to generate epidemic scenarios for emerging infectious diseases based on the use of key calendar events
This article's authors